A Study to Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

Clinical trial NCT06495203 · COMPLETED

Trial details

NCT number: NCT06495203
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Neovascular Age-related Macular Degeneration Retinal Vein Occlusion

Start date: 2023-11-02
Primary completion: 2024-02-29
Enrollment: 1350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.